Display options
Cite
Kugadas A, Christiansen SH, Sankaranarayanan S, et al. Impact of Microbiota on Resistance to Ocular Pseudomonas aeruginosa-Induced Keratitis. PLoS Pathog. 2016;12(9):e1005855doi: 10.1371/journal.ppat.1005855.
Kugadas, A., Christiansen, S. H., Sankaranarayanan, S., Surana, N. K., Gauguet, S., Kunz, R., Fichorova, R., Vorup-Jensen, T., & Gadjeva, M. (2016). Impact of Microbiota on Resistance to Ocular Pseudomonas aeruginosa-Induced Keratitis. PLoS pathogens, 12(9), e1005855. https://doi.org/10.1371/journal.ppat.1005855
Kugadas, Abirami, et al. "Impact of Microbiota on Resistance to Ocular Pseudomonas aeruginosa-Induced Keratitis." PLoS pathogens vol. 12,9 (2016): e1005855. doi: https://doi.org/10.1371/journal.ppat.1005855
Kugadas A, Christiansen SH, Sankaranarayanan S, Surana NK, Gauguet S, Kunz R, Fichorova R, Vorup-Jensen T, Gadjeva M. Impact of Microbiota on Resistance to Ocular Pseudomonas aeruginosa-Induced Keratitis. PLoS Pathog. 2016 Sep 22;12(9):e1005855. doi: 10.1371/journal.ppat.1005855. eCollection 2016 Sep. PMID: 27658245; PMCID: PMC5033354.
Copy Download .nbib Format: NLM
Share it on

PLoS Pathog. 2016 Sep 22;12(9):e1005855. doi: 10.1371/journal.ppat.1005855. eCollection 2016 Sep.

Impact of Microbiota on Resistance to Ocular Pseudomonas aeruginosa-Induced Keratitis.

PLoS pathogens

Abirami Kugadas, Stig Hill Christiansen, Saiprasad Sankaranarayanan, Neeraj K Surana, Stefanie Gauguet, Ryan Kunz, Raina Fichorova, Thomas Vorup-Jensen, Mihaela Gadjeva

Affiliations

  1. Department of Medicine, Division of Infectious Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, United States of America.
  2. Department of Biomedicine, Aarhus University, Aarhus, Denmark.
  3. Department of Medicine, Division of Infectious Diseases, Boston Children's Hospital, Boston, Massachusetts, United States of America.
  4. Department of Pediatrics and Anesthesia, UMass Memorial Children's Medical Center, University of Massachusetts Medical School, Worcester, Massachusetts, United States of America.
  5. Thermo Fisher Scientific Center for Multiplexed Proteomics, Harvard Medical School, Boston, Massachusetts, United States of America.
  6. Laboratory of Genital Tract Biology, Department of Obstetrics, Gynecology and Reproductive Biology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, United States of America.

PMID: 27658245 PMCID: PMC5033354 DOI: 10.1371/journal.ppat.1005855

Abstract

The existence of the ocular microbiota has been reported but functional analyses to evaluate its significance in regulating ocular immunity are currently lacking. We compared the relative contribution of eye and gut commensals in regulating the ocular susceptibility to Pseudomonas aeruginosa-induced keratitis. We find that in health, the presence of microbiota strengthened the ocular innate immune barrier by significantly increasing the concentrations of immune effectors in the tear film, including secretory IgA and complement proteins. Consistent with this view, Swiss Webster (SW) mice that are typically resistant to P. aeruginosa-induced keratitis become susceptible due to the lack of microbiota. This was exemplified by increased corneal bacterial burden and elevated pathology of the germ free (GF) mice when compared to the conventionally maintained SW mice. The protective immunity was found to be dependent on both eye and gut microbiota with the eye microbiota having a moderate, but significant impact on the resistance to infection. These events were IL-1ß-dependent as corneal IL-1ß levels were decreased in the infected GF and antibiotic-treated mice when compared to the SPF controls, and neutralization of IL-1ß increased the ocular bacterial burden in the SPF mice. Monocolonizing GF mice with Coagulase Negative Staphylococcus sp. isolated from the conjunctival swabs was sufficient to restore resistance to infection. Cumulatively, these data underline a previously unappreciated role for microbiota in regulating susceptibility to ocular keratitis. We predict that these results will have significant implications for contact lens wearers, where alterations in the ocular commensal communities may render the ocular surface vulnerable to infections.

Conflict of interest statement

The authors have declared that no competing interests exist.

References

  1. Best Pract Res Clin Gastroenterol. 2016 Feb;30(1):111-8 - PubMed
  2. Methods Mol Biol. 2014;1100:373-9 - PubMed
  3. Ocul Surf. 2016 Jul;14 (3):342-9 - PubMed
  4. Scand J Infect Dis Suppl. 1982;35:9-15 - PubMed
  5. Nat Med. 2014 Nov;20(11):1334-9 - PubMed
  6. Biomed Rep. 2016 Jul;5(1):35-40 - PubMed
  7. Exp Eye Res. 2013 Dec;117:99-105 - PubMed
  8. Nat Rev Immunol. 2013 Nov;13(11):790-801 - PubMed
  9. Bioinformatics. 2010 Jan 1;26(1):139-40 - PubMed
  10. Invest Ophthalmol Vis Sci. 1992 Sep;33(10):2908-16 - PubMed
  11. Genome Med. 2016 Apr 21;8(1):44 - PubMed
  12. J Immunol. 2010 Oct 1;185(7):4272-83 - PubMed
  13. Microb Ecol. 2015 Feb;69(2):407-14 - PubMed
  14. Prog Retin Eye Res. 2004 Jan;23(1):1-30 - PubMed
  15. J Clin Gastroenterol. 2014 Sep;48(8):693-702 - PubMed
  16. Methods. 2001 Dec;25(4):402-8 - PubMed
  17. Curr Opin Gastroenterol. 2014 Jan;30(1):97-105 - PubMed
  18. Nat Methods. 2011 Oct 02;8(11):937-40 - PubMed
  19. Optom Vis Sci. 2012 Mar;89(3):326-35 - PubMed
  20. J Clin Microbiol. 1992 May;30(5):1156-61 - PubMed
  21. Nature. 2013 Oct 3;502(7469):96-9 - PubMed
  22. Nat Med. 2014 May;20(5):524-30 - PubMed
  23. Clin Res Hepatol Gastroenterol. 2015 Feb;39(1):9-19 - PubMed
  24. Am J Ophthalmol. 2013 Jan;155(1):36-44.e2 - PubMed
  25. Curr Eye Res. 2004 Oct-Nov;29(4-5):225-33 - PubMed
  26. Invest Ophthalmol Vis Sci. 2004 Sep;45(9):3177-84 - PubMed
  27. J Immunol. 2014 Nov 15;193(10):5273-83 - PubMed
  28. Am J Ophthalmol. 2013 Jun;155(6):961-970.e2 - PubMed
  29. Nature. 2015 Apr 2;520(7545):104-8 - PubMed
  30. J Immunol. 2012 Nov 1;189(9):4231-5 - PubMed
  31. Optom Vis Sci. 1996 Mar;73(3):204-7 - PubMed
  32. Anal Chem. 2014 Jul 15;86(14):7150-8 - PubMed
  33. J Immunol. 2010 Apr 15;184(8):4123-32 - PubMed
  34. Curr Opin Immunol. 2010 Aug;22(4):455-60 - PubMed
  35. Anal Chem. 2008 Jun 15;80(12):4741-51 - PubMed
  36. Acta Ophthalmol (Copenh). 1994 Apr;72(2):241-5 - PubMed
  37. Curr Eye Res. 1993 Nov;12(11):1001-7 - PubMed
  38. MBio. 2016 Mar 22;7(2):e00198 - PubMed
  39. Nat Immunol. 2009 Nov;10(11):1208-14 - PubMed
  40. Invest Ophthalmol Vis Sci. 2007 Dec;48(12):5616-23 - PubMed
  41. Am J Ophthalmol. 2008 Jan;145(1):136-142 - PubMed
  42. DNA Cell Biol. 2009 Aug;28(8):405-11 - PubMed
  43. Hum Mol Genet. 2016 Oct 1;25(R2):R106-R114 - PubMed
  44. Proc Natl Acad Sci U S A. 2011 Mar 29;108(13):5354-9 - PubMed
  45. CLAO J. 1992 Jan;18(1):53-5 - PubMed
  46. Invest Ophthalmol Vis Sci. 2015 Jul;56(8):4582-91 - PubMed
  47. Infect Immun. 1995 Sep;63(9):3497-501 - PubMed
  48. Infect Immun. 2015 Oct;83(10):4003-14 - PubMed
  49. Nature. 2015 Sep 24;525(7570):528-32 - PubMed
  50. Curr Eye Res. 1989 Apr;8(4):329-35 - PubMed
  51. Nat Methods. 2016 Sep;13(9):731-40 - PubMed
  52. Eur J Immunol. 2007 Sep;37(9):2509-17 - PubMed
  53. Nat Med. 2010 Feb;16(2):228-31 - PubMed
  54. Infect Immun. 2014 Aug;82(8):3483-91 - PubMed
  55. Cell. 2012 Jun 22;149(7):1578-93 - PubMed
  56. Cell Host Microbe. 2012 Oct 18;12(4):496-508 - PubMed
  57. Cell Syst. 2016 Mar 23;2(3):159-71 - PubMed
  58. Cell Host Microbe. 2010 Feb 18;7(2):140-50 - PubMed
  59. PLoS One. 2011 Mar 21;6(3):e17996 - PubMed
  60. Infect Immun. 2014 Oct;82(10):4204-11 - PubMed
  61. Genome Res. 2009 Apr;19(4):636-43 - PubMed
  62. Acta Ophthalmol (Copenh). 1981 Jun;59(3):387-401 - PubMed

Publication Types

Grant support